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Gregory L. Moneta, MD, Section EditorInﬂuence of Aortic Valve Calcium on Outcome in Patients Undergoing
Peripheral Vascular Surgery
Valentijn TM, Hoeks SE, Bakker EJ, et al. Am J Cardiol 2012;110:1195-9.
Conclusion: Aortic valve calcium is common in vascular surgical
patients. Aortic stenosis is associated with negative postoperative and
long-term outcomes.
Summary: An increased propensity for left ventricular dysfunction
and silent coronary artery disease places vascular surgery patients at an
increased risk for adverse cardiac events after surgery. The Revised Cardiac
Risk Index (RCRI) is commonly used for preoperative risk stratiﬁcation.
The RCRI awards 1 point for each of the following characteristics: high-
risk surgery, coronary heart disease, history of congestive heart failure,
history of cerebrovascular disease, insulin therapy for diabetes, and renal
insufﬁciency as deﬁned by a creatinine >2.0 mg/dL. Aortic valve calcium
is also associated with cardiovascular mortality in the general population.
The present study evaluated the prognostic implications of aortic valve
calcium on 30-day postoperative and long-term outcomes of vascular
surgery patients. Patients were also assessed for usual vascular atherosclerotic
risk factors and with the RCRI. Echocardiographic aortic valve evaluation
was completed in 1172 vascular surgery patients. Sclerosis of the aortic valve
was deﬁned by the presence of thickening or calcium of more than one cusp
of a tricuspid aortic valve without actual stenosis (ie, a maximum cross-
valve velocity determined by continuous-wave Doppler of <2.5 m/s), or
both. Stenosis of the aortic valve was deﬁned as a maximum velocity of
>2.5 m/s. Troponin-T measurements and electrocardiograms were
routinely performed after surgery. Study end points included a composite
of postoperative cardiovascular events and long-term mortality. Aortic valve
sclerosis was present in 416 patients (36%), and aortic valve stenosis was
present in 30 patients (3%). Multivariate regression analysis adjusted for
age, sex, RCRI, hypertension, hypercholesterolemia, and medication use
indicated aortic valve sclerosis was not associated with postoperative or
long-term outcomes. In contrast, however, aortic valve stenosis was associ-
ated with greater event rates postoperatively (odds ratio, 3.9; 95% conﬁ-
dence interval, 1.7-8.7) and long-term (hazard ratio, 2.1; 95% conﬁdence
interval, 1.2-3.7).
Comment: Basically, the article says that aortic valve calcium is
common in vascular surgical patients, but until calciﬁcation progresses to
the point of producing aortic stenosis, which is uncommon in vascular
surgical patients (3% in this series), aortic valve calcium is no better than
the RCRI in predicting short-term and long-term mortality in patients
undergoing vascular surgery. As is the case with many other proposed
markers for increased mortality in vascular surgical patients, the use of
adjuncts to a thorough history and physical examination is not all that help-
ful in stratifying short-term or long-term mortality in the vascular surgical
patient.Usefulness of Hemoglobin Level to Predict Long-term Mortality in
Patients With Asymptomatic Carotid Narrowing by Ultrasonography
Goliasch G, Schillinger M, Mayer Florian FJ, et al. Am J Cardiol 2012;110:
1699-703.
Conclusion: There is a signiﬁcant association with hemoglobin level
and all-cause mortality and cardiovascular mortality in patients with carotid
stenosis.
Summary: Anemia can be associated with cardiovascular outcome in
healthy individuals. However, the effects of anemia on patients with cardio-
vascular disease have not been fully understood or studied in detail in
speciﬁc subsets of patients with cardiovascular disease. Intervention in
patients with asymptomatic carotid stenosis is somewhat controversial,
and clearly, the number needed to treat to prevent stroke in patients with
asymptomatic carotid stenosis is high compared with the number needed
to treat to prevent stroke in patients with symptomatic carotid stenosis.
The determination of the natural history of patients with asymptomatic
carotid stenosis, particularly with respect to long-term survival, may help
further stratify patients with asymptomatic carotid stenosis to those most
appropriate, or perhaps less appropriate, for intervention. In this study,
the authors tested the long-term inﬂuence of hemoglobin level on all-cause
and cardiovascular mortality in patients with atherosclerotic disease. They
prospectively studied 1065 of 1286 consecutive patients identiﬁed withasymptomatic carotid stenosis. Of these, 275 patients (25.8%) died during
a median follow-up of 6.2 years, corresponding to 5551 person-years.
Continuous measures of hemoglobin displayed a signiﬁcant inverse effect
on all-cause mortality and cardiovascular mortality, with adjusted hazard
ratio (HR) for increase of 1 standard deviation of hemoglobin of 0.73
(95% conﬁdence interval [CI], 0.64-0.83; P < .001) and an adjusted HR
of 0.76 (95% CI 0.64-0.89; P ¼ .001) respectively. Six year cumulative
survival rates were 61%, 79%, 80%, and 81%, in the ﬁrst, second, third,
and fourth quartiles of hemoglobin (log-rank, P < .001). Patients in the ﬁrst
hemoglobin quartile (<12.9 g/dL) had an increased risk of all-cause
mortality (adjusted HR, 1.93; 95% CI, 1.46-2.54; P < .001) and cardiovas-
cular mortality (adjusted HR, 1.68; 95% CI, 1.19-2.36; P ¼ .003)
compared with patients with greater hemoglobin levels.
Comment: The data indicate low hemoglobin levels (<12.9 g/dL) in
patients with asymptomatic carotid stenosis are a marker of increased all-
cause and cardiovascular mortality. The mechanism of chronic anemia
leading to increased mortality is unknown and likely complex. Anemia
may lead to late ventricular remodeling and long-lasting ﬂow/volume over-
load and increased cardiac work, with resulting left ventricular hypertrophy
and increased risk of heart failure (Varat MA et al, Am Heart J
1972;83:415-26; Jeong SK et al, Cardiovasc Drugs Ther 2010;24:151-
60). Unfortunately, the data here were not stratiﬁed for the degree of
carotid stenosis. Therefore, although anemia may be a marker for increased
mortality in patients with asymptomatic carotid stenosis, the magnitude of
this increase compared with the stroke risk of high-grade carotid stenosis
remains uncertain.Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection
Climo MW, Yokoe DS, Warren DK, et al. N Engl J Med 2013;368:533-42.
Conclusion: Daily bathing with chlorhexidine-impregnated wash-
cloths reduces the risk of acquisition of multidrug-resistant organisms
(MDROs) and the development of hospital-acquired bloodstream
infections.
Summary: MDROs are endemic in many hospitals. It has been shown
that targeted interventions, particularly in intensive care units, can reduce
the risk of hospital-acquired bloodstream infections. Several studies have
shown modiﬁcation of catheter insertion processes, including insertion site
antisepsis with chlorhexidine-containing products, decreases risk of infection
(Pronvost P et al, N Engl J Med 2006;355:2725-32). There is, however,
more controversy regarding the use of antiseptic agents for patient bathing.
Chlorhexidine gluconate has broad-spectrum activity against many organ-
isms, including Staphylococcus aureus and enterococci. Chlorhexidine-
impregnated cloths can reduce the number of vancomycin-resistant
enterococci (VRE) colonies on skin by 2.5 log and can decrease VRE
contamination of health care workers’ hands by 40% and environmental
surfaces by 30% (Vernon MO et al, Arch Intern Med 2006;166:306-12).
In addition, daily bathing with 2% chlorhexidine-impregnated washcloths
can reduce primary bloodstream infections by 60% (Bleasdale SC et al,
Arch Intern Med 2007;167:2073-9; Climo MW et al, Crit Care Med
2009;37:1858-65). These previous studies have, however, primarily been
single-center, before-and-after, observational studies. The current study
uses more sound scientiﬁc methodology. This multicenter, cluster-random-
ized, crossover trial evaluated the effect of daily bathing with chlorhexidine-
impregnated washcloths on acquisition of MDROs and the incidence of
hospital-acquired bloodstream infection. Participating units were randomly
assigned to bathe patients with no-rinse 2% chlorhexidine-impregnated wash-
cloths or with non-antimicrobial washcloths for 6 months. In the next 6
months, there was an exchange for the alternate product. The incidence rates
of acquisition of MDROs and the rates of hospital-acquired bloodstream
infection were compared between the two periods bymean of Poisson regres-
sion analysis. The study enrolled 7727 patients. The overall rate of MDRO
acquisition per 1000 patient-days was 5.10 with chlorhexidine bathing vs
6.60 with non-antimicrobial washcloths (P ¼ .03). This was the equivalent
of a 23% lower rate with chlorhexidine bathing. The overall rate of
hospital-acquired bloodstream infection per 1000 patient-days was 4.78 cases
with chlorhexidine bathing vs 6.60 cases with non-antimicrobial washcloths
(P ¼ .007). This is a 28% lower rate with chlorhexidine-impregnated wash-
cloths. No signiﬁcant skin reactions were noted during this study.1719
